| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,077 |
14,691 |
$1.15M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,391 |
6,228 |
$609K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,472 |
2,321 |
$245K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
327 |
323 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,069 |
1,026 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
168 |
166 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
234 |
232 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,199 |
1,147 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
100 |
95 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
78 |
77 |
$610.43 |
| 87400 |
|
17 |
16 |
$436.46 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
146 |
131 |
$276.38 |
| 81003 |
|
46 |
37 |
$55.54 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
51 |
49 |
$2.93 |
| 96161 |
|
86 |
86 |
$1.28 |